Trending Market News
The U.S. FDA has approved Merck's once-daily oral combination therapy for HIV-1 infections, pairing doravirine (already sold as Pifeltro) with experimental drug islatravir. The two-drug regimen is designed to replace current antiretroviral treatments for some adults living with HIV-1. This approval comes as approximately 40.8 million people worldwide live with HIV, with 1.3 million new infections annually.
- The combination therapy pairs Merck's already-approved doravirine (marketed as Pifeltro and Delstrigo) with the experimental treatment islatravir
- The regimen is approved to replace existing antiretroviral treatments for HIV-1 infection in certain adult patients
- Globally, 40.8 million people live with HIV and roughly 1.3 million new infections occur each year, according to NIH data
Ukraine has completed repairs on the Druzhba oil pipeline damaged by Russian strikes, clearing the way for Russian oil flows to Europe to resume. President Zelenskiy announced the restart and expects a 90 billion euro EU aid package, previously blocked by Hungary's Prime Minister Viktor Orban, to now be unblocked. The pipeline suspension had sparked outrage from Hungary and Slovakia, which depend on Russian oil imports.
- Hungary's government had threatened to cut energy aid to Ukraine and blocked the 90 billion euro EU aid package in response to the pipeline suspension
- Ukraine's wartime budget depends heavily on foreign financing, and Zelenskiy directly linked the pipeline repairs to unblocking the European support package
- Russia confirmed readiness to resume oil flows through the pipeline after Ukraine completed repairs on the section damaged by Russian strikes
Forge Nano, a U.S. semiconductor equipment and advanced materials company, announced plans to go public through a $1.6 billion SPAC merger with Archimedes Tech SPAC Partners II. The deal, expected to close in the second half of 2026, will generate up to $342 million in gross proceeds to scale U.S. manufacturing and expand into high-growth markets including AI data centers and quantum computing.
- The transaction comes amid surging demand for AI chips as companies increase spending on data centers and high-performance computing for generative AI applications
- Forge Nano is backed by major investors including Volkswagen, GM Ventures, and LG Technology Ventures, and has received a $100 million grant from the U.S. Department of Energy
- The combined entity will trade on Nasdaq under ticker 'NANO', with proceeds funding semiconductor tool manufacturing, lithium-ion battery production, and expansion into pharmaceuticals and quantum computing markets
Oil prices surged over 55% since the U.S.-Israeli war against Iran began in late February 2026, with Brent crude jumping from around $72 to nearly $120 per barrel at its peak. The conflict disrupted energy exports through the Strait of Hormuz and halted production across Gulf states. Markets remain volatile as ceasefire talks continue and the strait remains functionally closed.
- Brent crude gained 51% in March alone, one of the largest monthly oil price increases on record, as Iranian attacks closed Gulf navigation and halted energy production from Qatar to Iraq
- The war began February 28 with joint U.S.-Israel strikes killing Iran's Supreme Leader Ayatollah Ali Khamenei, followed by Iranian retaliation against Gulf infrastructure and energy facilities
- Analysts expect Brent to stabilize in the $80-90 range if the Strait of Hormuz reopens, but supply chain damage and production outages will prevent a full return to pre-crisis levels around $72
Moderna announced on April 21 that the European Commission has approved its combination vaccine targeting both influenza and COVID-19 for adults aged 50 and older. This marks the first regulatory approval for Moderna's combo shot in the European market, offering a streamlined vaccination option for senior populations.
- The marketing authorization applies specifically to adults 50 years of age and older in European Union member states
- The combination vaccine allows simultaneous protection against both flu and COVID-19 in a single shot, potentially improving vaccination compliance among seniors
- This approval expands Moderna's mRNA vaccine portfolio beyond standalone COVID-19 products in the EU market
UPS and FedEx have begun filing for tariff refunds through a new government portal after the Supreme Court ruled in February that tariffs collected under the International Emergency Economic Powers Act were unconstitutional. The refund process could take up to three months, with both shipping companies committing to pass refunds through to customers who initially bore the charges.
- The refund portal only covers tariffs collected under IEEPA that were ruled unconstitutional; other tariffs under Section 232 and Section 301 remain in place
- U.S. Customs and Border Protection will process refund requests in phases, with the first phase covering only entries finalized within the last 80 days
- UPS estimates it could take up to three months to receive refunds from CBP before issuing them to customers, who do not need to contact the company directly
President Trump indicated on Tuesday that the federal government might provide assistance to Spirit Airlines, which is facing potential liquidation. Speaking on CNBC's 'Squawk on the Street,' Trump expressed support for either a merger or direct government aid for the struggling discount carrier.
- Trump stated he would support a merger, saying 'I'd love somebody to buy Spirit' and acknowledged the airline is 'in trouble'
- The President suggested possible federal government intervention to help Spirit Airlines avoid liquidation
- This marks a potential shift in administration policy toward assisting a struggling budget airline amid financial distress
AstraZeneca CEO warned that Germany may not receive new drug launches if the country proceeds with plans to tighten pharmaceutical spending controls. Germany's coalition government announced proposals to reduce a 20 billion euro health insurance funding gap by imposing steeper mandatory discounts on patented drugs. The drugmaker cited pressure from U.S. pricing policies as a key factor forcing difficult decisions about market access.
- Germany plans to implement variable discounts on patented drugs tied to overall expenditures and contributions, which AstraZeneca's CEO called 'a dangerous backward step'
- The threat reflects broader industry pushback against U.S. most-favored-nation pricing efforts that would tie American drug prices to lower European levels
- AstraZeneca's CEO warned Europe risks becoming merely a sales region rather than a hub for research, development, and manufacturing if pricing pressures continue
U.S. retail sales rose 1.7% in March, exceeding the 1.4% forecast, primarily driven by a 24.1% surge in gasoline prices resulting from the U.S.-Israeli conflict with Iran. The increase was also supported by higher auto sales and tax refunds, though core retail sales excluding volatile categories grew a more modest 0.7%.
- Global oil prices jumped over 30% due to the Iran conflict, adding an estimated $857 to Americans' average annual gasoline costs for the year
- Core retail sales (excluding autos, gas, building materials, and food services) rose 0.7%, suggesting consumer spending growth slowed from Q4's 1.9% annualized rate
- Consumer sentiment fell to a record low in April amid concerns that high gas prices could divert spending from other sectors and erode tax refunds
Swedish trucking company Einride has partnered with Amazon to deploy 75 electric heavy-duty trucks and charging infrastructure across five U.S. locations for Amazon's freight network. The partnership leverages Einride's Saga AI software for fleet management and represents Amazon's strategy of working with third-party operators to advance electrification without directly owning all assets. This comes as the U.S. electric trucking market faces challenges and slower-than-expected adoption.
- Einride's proprietary Saga AI optimization software will manage electric vehicle execution for select Amazon loads, including charging planning
- Amazon is increasingly relying on operators like Einride that provide vehicles, charging infrastructure, and fleet-management software rather than owning and operating all electrification assets directly
- The U.S. electric trucking market has struggled to meet early expectations, with setbacks at companies like Nikola and slower rollouts of Amazon's electric delivery vans developed with Rivian
Quest Diagnostics raised its 2026 profit and revenue outlook after first-quarter results exceeded Wall Street expectations, driven by strong demand for routine diagnostic testing. The company now expects full-year revenue between $11.78 billion and $11.90 billion, up from its previous forecast, as it navigates post-pandemic normalization with hospital laboratory management deals and routine testing volumes.
- Quest's Diagnostic Information Services revenue rose 9.4% year-over-year to $2.83 billion, with organic requisition volumes up 10.8%, though revenue per test fell 1.3%
- First-quarter revenue reached $2.90 billion versus analyst estimates of $2.83 billion, with adjusted profit of $2.50 per share beating expectations
- The company reported double-digit revenue growth in advanced diagnostics including Alzheimer's blood tests and cardiometabolic testing, though analysts caution new hospital contracts may pressure margins initially
Danaher exceeded first-quarter profit expectations on April 21, reporting adjusted earnings of $2.06 per share, driven by strong demand for bioprocessing tools used in drug manufacturing. The results indicate improving market conditions for life sciences companies as pharmaceutical firms increase spending on drug discovery and development.
- The bioprocessing unit was the standout performer with core sales up 7% for the quarter, while total quarterly revenue of $5.95 billion slightly missed Wall Street estimates of $6 billion
- Life sciences segment core sales rose 0.5%, but the diagnostics unit (including COVID-19 testing kits) saw sales decline 4% amid weaker seasonal demand for respiratory tests
- Danaher raised its full-year adjusted earnings forecast to $8.35-$8.55 per share and expressed optimism about its acquisition of Masimo Corporation announced in February
Defense contractor RTX raised its 2026 profit and revenue forecasts on Tuesday, driven by strong demand for missile systems and weapons amid heightened geopolitical tensions. The company benefits from Pentagon efforts to replenish stockpiles depleted by conflicts in Ukraine and Gaza, as well as robust aircraft maintenance demand due to airline supply chain disruptions.
- RTX secured a $3.7 billion contract in April to supply Patriot GEM-T interceptor missiles to Ukraine, while its Raytheon unit saw first-quarter sales jump 10% to $6.95 billion
- First-quarter revenue rose 9% year-over-year to $22.08 billion, with commercial aftermarket sales up 19% in the Pratt and Whitney segment as airlines maintain aging fleets
- The company lifted its 2026 revenue forecast to $92.5-$93.5 billion from $92-$93 billion previously, citing sustained aftermarket sales and growing weapons demand
Merck and Eisai announced that their experimental combination treatments for a type of kidney cancer failed to meet the primary endpoints in a late-stage clinical trial. The setback affects the companies' joint development efforts in oncology. This news represents a significant clinical disappointment for the pharmaceutical partners' cancer drug pipeline.
- The experimental combination therapy was being tested for a specific type of kidney cancer in a late-stage study
- The treatment failed to achieve its main goals, indicating the drug combination did not demonstrate sufficient efficacy in the trial
- This failure impacts Merck and Eisai's collaborative oncology development program and may affect their strategic plans in kidney cancer treatment
Halliburton reported increased first-quarter profit on Tuesday, with net income reaching $461 million, or 55 cents per share. The oilfield services provider benefited from steady demand in Latin America and European markets, which offset a slowdown in Middle East activity due to the Iran war.
- Net income attributable to the company was $461 million, or 55 cents per share
- Strong performance in Latin America and European markets compensated for reduced activity levels
- Middle East operations experienced a slowdown due to the Iran war
Northrop Grumman reported a 4.4% increase in first-quarter revenue to $9.88 billion, driven by strong demand for aeronautics systems including the B-21 Raider aircraft and nuclear missile programs. The growth reflects increased Pentagon procurement amid global conflicts straining weapons stockpiles, with the company maintaining its 2026 sales forecast of $43.5 to $44 billion.
- Aeronautics segment sales rose 17% to $3.28 billion, boosted by a February agreement to expand B-21 Raider production by 25% with first deliveries scheduled for 2027 at $692 million per aircraft
- Defense systems segment saw 10% organic sales growth to $1.9 billion, driven by the Sentinel nuclear missile program (replacing Minuteman III) with first flight expected in 2027
- Pentagon efforts to rebuild weapons stockpiles depleted by Iran-linked operations and other conflicts are fueling sustained demand for defense contractors
India's Competition Commission (CCI) has changed AB InBev's status from witness to 'party under investigation' in a cartel probe involving 42 alcohol retailers in Telangana state, allegedly excluding AB InBev's rivals. The world's largest brewer secured a temporary court injunction in April 2025, arguing the status change was illegal without prior notice. If the investigation proceeds, AB InBev could face penalties up to three times its profit or 10% of annual turnover.
- AB InBev cooperated as a witness for four years (2022-2025) and shared sensitive business information before being reclassified as an accused party in November 2025 without prior notice or hearing
- The CCI alleges retailers formed a cartel to exclusively stock AB InBev products and receive special incentives, excluding rivals Heineken (50% market share), Carlsberg (19%), and United Breweries from India's $10 billion beer market
- This is India's toughest beer sector enforcement since 2021 when Heineken and Carlsberg were collectively fined over $100 million for price collusion, a case where AB InBev was a witness
Russia will halt Kazakhstan's oil shipments to Germany through the Druzhba pipeline starting May 1, according to industry sources who confirmed updated export schedules have been sent to both countries. The move comes amid deteriorating Russia-Germany relations over the Ukraine conflict and affects a key supply route for Germany's PCK refinery in Schwedt.
- Kazakhstan exported 2.146 million metric tons (approximately 43,000 barrels per day) of oil to Germany via Druzhba in 2025, a 44% increase from 2024
- Germany's PCK refinery in Schwedt has relied on Kazakh crude via this pipeline since Russian oil deliveries stopped in 2022 following Moscow's invasion of Ukraine
- The pipeline route through Russia and Poland has faced repeated interruptions from Ukrainian drone attacks on Russian territory
U.S. Trade Representative Jamieson Greer informed Mexican auto and steel industries that Trump's tariffs will remain in place even after USMCA renegotiation, marking the first time the administration has explicitly stated tariffs won't return to zero. Mexico faces 25% tariffs on automotive imports and steel products, putting it at a disadvantage compared to countries like Japan and the EU that secured lower rates. Formal bilateral talks are set to begin the week of May 25 ahead of a July 1 USMCA review deadline.
- Mexico's auto exports to the U.S. fell nearly 3% in 2025 after Trump imposed 25% tariffs in March 2025, with the sector losing about 60,000 jobs and facing deeper declines if tariffs persist
- U.S. negotiators proposed requiring 100% of key auto components (engines, major electronics, software) be sourced from North America, up from the current 75% regional value content requirement under USMCA
- Mexico now faces higher effective tariffs than competitors, as Trump granted lower rates to Japan, the EU, and South Korea (15%) and Britain (10%) on automotive imports
JPMorgan Chase is expanding its $1.5 trillion Security and Resiliency Initiative (SRI) to continental Europe after launching it in the U.S. and U.K. last year. The 10-year program aims to finance and invest in industries critical to economic security, including defense, energy, healthcare, and strategic technologies. CEO Jamie Dimon emphasized reducing reliance on unpredictable sources for critical materials essential to collective security and prosperity.
- The initiative focuses on five key European countries - U.K., France, Germany, Poland, and Italy - while including all EU and NATO member states in the strategy.
- Investment targets include around 30 subsectors spanning shipbuilding, spacecraft, nuclear energy, cybersecurity, semiconductors, and critical minerals supply chains.
- JPMorgan will provide preferential credit terms for SRI-aligned companies, including smaller size deals than typically expected, to scale up Western capabilities in strategic sectors.